These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30126255)

  • 1. Upregulation of Nrf2 and Decreased Redox Signaling Contribute to Renoprotective Effects of Chemerin Receptor Blockade in Diabetic Mice.
    Neves KB; Montezano AC; Alves-Lopes R; Bruder-Nascimento T; Costa RM; Costa RS; Touyz RM; Tostes RC
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemerin receptor blockade improves vascular function in diabetic obese mice via redox-sensitive and Akt-dependent pathways.
    Neves KB; Nguyen Dinh Cat A; Alves-Lopes R; Harvey KY; Costa RMD; Lobato NS; Montezano AC; Oliveira AM; Touyz RM; Tostes RC
    Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1851-H1860. PubMed ID: 30216119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemerin/ChemR23 axis promotes inflammation of glomerular endothelial cells in diabetic nephropathy.
    Shang J; Wang L; Zhang Y; Zhang S; Ning L; Zhao J; Cheng G; Liu D; Xiao J; Zhao Z
    J Cell Mol Med; 2019 May; 23(5):3417-3428. PubMed ID: 30784180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinnamaldehyde Ameliorates Vascular Dysfunction in Diabetic Mice by Activating Nrf2.
    Wang P; Yang Y; Wang D; Yang Q; Wan J; Liu S; Zhou P; Yang Y
    Am J Hypertens; 2020 Jul; 33(7):610-619. PubMed ID: 32242611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.
    Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
    Wang XX; Wang D; Luo Y; Myakala K; Dobrinskikh E; Rosenberg AZ; Levi J; Kopp JB; Field A; Hill A; Lucia S; Qiu L; Jiang T; Peng Y; Orlicky D; Garcia G; Herman-Edelstein M; D'Agati V; Henriksen K; Adorini L; Pruzanski M; Xie C; Krausz KW; Gonzalez FJ; Ranjit S; Dvornikov A; Gratton E; Levi M
    J Am Soc Nephrol; 2018 Jan; 29(1):118-137. PubMed ID: 29089371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antioxidant peptide SS31 prevents oxidative stress, downregulates CD36 and improves renal function in diabetic nephropathy.
    Hou Y; Shi Y; Han B; Liu X; Qiao X; Qi Y; Wang L
    Nephrol Dial Transplant; 2018 Nov; 33(11):1908-1918. PubMed ID: 30388276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes aggravates renal ischemia and reperfusion injury in rats by exacerbating oxidative stress, inflammation, and apoptosis.
    Gong DJ; Wang L; Yang YY; Zhang JJ; Liu XH
    Ren Fail; 2019 Nov; 41(1):750-761. PubMed ID: 31441362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
    Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
    Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of Chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats.
    Hu W; Yu Q; Zhang J; Liu D
    Inflammation; 2012 Aug; 35(4):1287-93. PubMed ID: 22350950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Superoxide Dismutase Attenuates Renal Oxidative Stress Through the Activation of Adenosine Monophosphate-Activated Protein Kinase in Diabetic Nephropathy.
    Hong YA; Lim JH; Kim MY; Kim Y; Park HS; Kim HW; Choi BS; Chang YS; Kim HW; Kim TY; Park CW
    Antioxid Redox Signal; 2018 Jun; 28(17):1543-1561. PubMed ID: 29020797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arctigenin ameliorates renal impairment and inhibits endoplasmic reticulum stress in diabetic db/db mice.
    Zhang J; Cao P; Gui J; Wang X; Han J; Wang Y; Wang G
    Life Sci; 2019 Apr; 223():194-201. PubMed ID: 30898648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notoginsenoside R1 Protects db/db Mice against Diabetic Nephropathy via Upregulation of Nrf2-Mediated HO-1 Expression.
    Zhang B; Zhang X; Zhang C; Shen Q; Sun G; Sun X
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30634720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.
    Ma T; Zheng Z; Guo H; Lian X; Rane MJ; Cai L; Kim KS; Kim KT; Zhang Z; Bi L
    Toxicol Appl Pharmacol; 2019 May; 370():93-105. PubMed ID: 30876865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
    Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
    Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.
    Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H
    Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2.
    Wu H; Kong L; Cheng Y; Zhang Z; Wang Y; Luo M; Tan Y; Chen X; Miao L; Cai L
    Free Radic Biol Med; 2015 Dec; 89():431-42. PubMed ID: 26415026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation.
    Zhang J; Liu L; Zhang Y; Yuan Y; Miao Z; Lu K; Zhang X; Ni R; Zhang H; Zhao Y; Wang X
    Redox Biol; 2022 Dec; 58():102554. PubMed ID: 36446229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling.
    Zhang Y; Qu Y; Cai R; Gao J; Xu Q; Zhang L; Kang M; Jia H; Chen Q; Liu Y; Ren F; Zhou MS
    Eur J Pharmacol; 2024 Aug; 976():176699. PubMed ID: 38825302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.
    Sedeek M; Callera G; Montezano A; Gutsol A; Heitz F; Szyndralewiez C; Page P; Kennedy CR; Burns KD; Touyz RM; Hébert RL
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1348-58. PubMed ID: 20630933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.